1. Fernandez-del Castillo C, Adsay NV. Intraductal papillary mucinous neoplasms of the pancreas. Gastroenterology 2010; 139:708–713. [PubMed]
2. Charlesworth M, Verbeke CS, Falk GA, et al. Pancreatic lesions in von Hippel-Lindau disease? A systematic review and meta-synthesis of the literature. J Gastrointest Surg 2012; 16:1422–1428. [PubMed]
3. Giudici F, Nesi G, Brandi ML, et al. Surgical management of insulinomas in multiple endocrine neoplasia type 1. Pancreas 2012; 41:547–553. [PubMed]
4. Del Chiaro M, Verbeke C, Salvia R, et al. European experts consensus statement on cystic tumours of the pancreas. Dig Liver Dis 2013; 45:703–711. [PubMed]
5. Heidt DG, Burant C, Simeone DM. Total pancreatectomy: indications, operative technique, and postoperative sequelae. J Gastrointest Surg 2007; 11:209–216. [PubMed]
6. Bramis K, Gordon-Weeks AN, Friend PJ, et al. Systematic review of total pancreatectomy and islet autotransplantation for chronic pancreatitis. Br J Surg 2012; 99:761–766. [PubMed]
7. Murphy MM, Knaus WJ, II, Ng SC, et al. Total pancreatectomy: a national study. HPB (Oxford) 2009; 11:476–482. [PMC free article][PubMed]
8. Stauffer JA, Nguyen JH, Heckman MG, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford) 2009; 11:483–492. [PMC free article][PubMed]
9. Siassi M, Klein P, Hohenberger W. Organ-preserving surgery for multicentric carcinoma of the pancreas. Eur J Surg Oncol 1999; 25:548–550. [PubMed]
10. Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg 2001; 25:452–460. [PubMed]
11. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138:8–13. [PubMed]
12. Wente MN, Veit JA, Bassi C, et al. Postpancreatectomy hemorrhage (PPH): an International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007; 142:20–25. [PubMed]
13. Buchler MW, Wagner M, Schmied BM, et al. Changes in morbidity after pancreatic resection: toward the end of completion pancreatectomy. Arch Surg 2003; 138:1310–1314. [PubMed]
14. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142:761–768. [PubMed]
15. Diabetes mellitus. Report of a WHO study group. Technical Report Series 646. 1980; http://whqlibdoc.who.int/trs/WHO_TRS_727.pdf Accessed November 3, 2016.
16. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21:2191–2192. [PubMed]
17. Fujita Y, Kozawa J, Iwahashi H, et al. Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area. Endocrine J 2015; 62:329–337. [PubMed]
18. Thibault V, Morisset AS, Brown C, et al. The increase in serum 25-hydroxyvitamin D following weight loss does not contribute to the improvement in insulin sensitivity, insulin secretion and beta-cell function. Br J Nutr 2015; 114:161–168. [PubMed]
19. Lloyd FP, Jr, Kang J. Multifocal papillary-cystic neoplasm of the pancreas. J Natl Med Assoc 2003; 95:1204–1207. [PMC free article][PubMed]
20. Miura F, Takada T, Amano H, et al. Middle-segment-preserving pancreatectomy. J Am Coll Surg 2007; 204:720–722. [PubMed]
21. Partelli S, Boninsegna L, Salvia R, et al. Middle-preserving pancreatectomy for multicentric body-sparing lesions of the pancreas. Am J Surg 2009; 198:e49–e53. [PubMed]
22. Matsubayashi H, Uesaka K, Kanemoto H, et al. Multiple endocrine neoplasms and serous cysts of the pancreas in a patient with von Hippel-Lindau disease. J Gastrointest Cancer 2010; 41:197–202. [PubMed]
23. Ohzato H, Yamamoto T, Fukunaga M, et al. Middle-preserving pancreatectomy for multifocal metastatic renal cell carcinoma located in the head, body and tail of the pancreas. A case report. JOP 2010; 11:633–637. [PubMed]
24. Sperti C, Polizzi ML, Moro M, et al. Middle-preserving pancreatectomy: an interesting procedure for pancreas-sparing resection. JOP 2010; 11:258–261. [PubMed]
25. Chen HW, Wang FJ, Lai EC, et al. Middle-preserving pancreatectomy for synchronous ampullary carcinoma and solid-pseudopapillary tumor of distal pancreas. Int J Surg Case Rep 2011; 2:267–268. [PMC free article][PubMed]
26. Horiguchi A, Ishihara S, Ito M, et al. Middle-segment-preserving pancreatectomy for biliary-pancreatic tumors. Hepatogastroenterology 2011; 58:1018–1021. [PubMed]
27. Cheng K, Shen BY, Peng CH, et al. Middle-preserving pancreatectomy: report of two cases and review of the literature. World J Surg Oncol 2013; 11:106. [PMC free article][PubMed]
28. Nishi M, Kawasaki H, Fujii M, et al. Middle-preserving pancreatectomy for multifocal intraductal papillary mucinous neoplasms of the pancreas: report of a case. Clin J Gastroenterol 2014; 7:251–254. [PMC free article][PubMed]
29. Takeshi A, Mitsuhiro I, Hiromitsu A, et al. Middle segment-preserving pancreatectomy for recurrent metastasis of renal cell carcinoma after pancreatoduodenectomy: a case report. Case Rep Surg 2014; 2014:648678. [PMC free article][PubMed]
30. Tanemura A, Mizuno S, Okura Y, et al. Margin-negative limited resection of metastatic pancreatic tumors from rectal cancer preoperatively diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsies: report of two cases. Surg Today 2014; 44:366–372. [PubMed]
31. Usui M, Kuriyama N, Uchida K, et al. Laparoscopy assisted middle-segment-preserving pancreatectomy for multiple pancreatic neuroendocrine tumors: report of a case. Asian J Endosc Surg 2014; 7:271–274. [PubMed]
32. Chiang KC, Hsu JT, Chen HY, et al. Multifocal intraductal papillary mucinous neoplasm of the pancreas—a case report. World J Gastroenterol 2009; 15:628–632. [PMC free article][PubMed]
33. Goyal J, Lipson EJ, Rezaee N, et al. Surgical resection of malignant melanoma metastatic to the pancreas: case series and review of literature. J Gastrointest Cancer 2012; 43:431–436. [PMC free article][PubMed]
34. Konstantinidis IT, Dursun A, Zheng H, et al. Metastatic tumors in the pancreas in the modern era. J Am Coll Surg 2010; 211:749–753. [PMC free article][PubMed]
35. Minter RM, Reith JD, Hochwald SN. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change. J Surg Oncol 2003; 82:201–208. [PubMed]
36. Okano K, Murakami Y, Nakagawa N, et al. Remnant pancreatic parenchymal volume predicts postoperative pancreatic exocrine insufficiency after pancreatectomy. Surgery 2016; 159:885–892. [PubMed]
The pancreas is an organ located in the abdomen. It plays an essential role in converting the food we eat into fuel for the body's cells. The pancreas has two main functions: an exocrine function that helps in digestion and an endocrine function that regulates blood sugar.
Location of the Pancreas
The pancreas is located behind the stomach in the upper left abdomen. It is surrounded by other organs including the small intestine, liver, and spleen. It is spongy, about six to ten inches long, and is shaped like a flat pear or a fish extended horizontally across the abdomen.
The wide part, called the head of the pancreas, is positioned toward the center of the abdomen. The head of the pancreas is located at the juncture where the stomach meets the first part of the small intestine. This is where the stomach empties partially digested food into the intestine, and the pancreas releases digestive enzymes into these contents.
The central section of the pancreas is called the neck or body.
The thin end is called the tail and extends to the left side.
Several major blood vessels surround the pancreas, the superior mesenteric artery, the superior mesenteric vein, the portal vein and the celiac axis, supplying blood to the pancreas and other abdominal organs.
Almost all of the pancreas (95%) consists of exocrine tissue that produces pancreatic enzymes for digestion. The remaining tissue consists of endocrine cells called islets of Langerhans. These clusters of cells look like grapes and produce hormones that regulate blood sugar and regulate pancreatic secretions.
Functions of the Pancreas
A healthy pancreas produces the correct chemicals in the proper quantities, at the right times, to digest the foods we eat.
The pancreas contains exocrine glands that produce enzymes important to digestion. These enzymes include trypsin and chymotrypsin to digest proteins; amylase for the digestion of carbohydrates; and lipase to break down fats. When food enters the stomach, these pancreatic juices are released into a system of ducts that culminate in the main pancreatic duct. The pancreatic duct joins the common bile duct to form the ampulla of Vater which is located at the first portion of the small intestine, called the duodenum. The common bile duct originates in the liver and the gallbladder and produces another important digestive juice called bile. The pancreatic juices and bile that are released into the duodenum, help the body to digest fats, carbohydrates, and proteins.
The endocrine component of the pancreas consists of islet cells (islets of Langerhans) that create and release important hormones directly into the bloodstream. Two of the main pancreatic hormones are insulin, which acts to lower blood sugar, and glucagon, which acts to raise blood sugar. Maintaining proper blood sugar levels is crucial to the functioning of key organs including the brain, liver, and kidneys.
Diseases of the Pancreas
Disorders affecting the pancreas include pancreatitis, precancerous conditions such as PanIN and IPMN, and pancreatic cancer. Each disorder may exhibit different symptoms and requires different treatments.
Pancreatitis is inflammation of the pancreas that occurs when pancreatic enzyme secretions build up and begin to digest the organ itself. It can occur as acute painful attacks lasting a matter of days, or it may be a chronic condition that progresses over a period of years.
Learn about pancreatitis, its causes, and treatment options in the pancreatitis section of this site.
Precursors to Pancreatic Cancer
The exact cause of pancreatic cancer is still unknown, but there are known risk factors that increase the risk of developing the disease. Cigarette smoking, a family history of pancreatic cancer or hereditary cancer syndromes, and chronic pancreatitis are some of these factors. In addition, certain pancreatic lesions such as Intraductal Papillary Mucinous Neoplasms (IPMNs) and Pancreatic Intraepithelial Neoplasia (PanIN) are considered precursors to pancreatic cancer.
Read more about precursors to pancreatic cancer here.
The most common form of pancreatic cancer is pancreatic adenocarcinoma, an exocrine tumor arising from the cells lining the pancreatic duct. A far less common form, endocrine tumors, account for less than 5% of all pancreatic tumors and are sometimes referred to as neuroendocrine or islet cell tumors.
Learn about the various forms of pancreatic cancer and their treatments here.